Informations générales (source: ClinicalTrials.gov)
Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response (OVAREX)
Observational
Centre Francois Baclesse (Voir sur ClinicalTrials)
mars 2019
août 2029
29 juin 2024
Development of ex vivo models of ovarian cancer, fallopian tubes or peritoneum.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Centre François BACLESSE - Caen - France | Enora DOLIVET, MD | Contact (sur clinicalTrials) | |||
Critères
Femme
Inclusion Criteria:
- Patient over 18 years old.
- Patient with ovarian cancer, carcinoma of the fallopian tubes, or histologically
proven peritoneum. All FIGO stages are accepted for the study.
- Patient to be managed by surgery (laparoscopy and / or laparotomy).
- Patient over 18 years old.
- Patient with ovarian cancer, carcinoma of the fallopian tubes, or histologically
proven peritoneum. All FIGO stages are accepted for the study.
- Patient to be managed by surgery (laparoscopy and / or laparotomy).
- Pregnant woman
- Persons deprived of liberty or guardianship (including curatorship)
- History of any other clinically active malignancy in the last 5 years prior to
inclusion